Through the creation of YB-1 knockdown MBGroup3 cell lines and subsequent transcriptomic analyses, the current study aimed to investigate the role of YB-1 in medulloblastoma tumourigenesis, with a focus on drug resistance. The gene discussed is YBX1; the disease is medulloblastoma.